TSE:ACBAurora Cannabis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aurora Cannabis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$13.05 -0.30 (-2.25 %) (As of 08/13/2020 09:30 AM ET) Add Compare Share Today's RangeC$12.92Now: C$13.05▼C$13.4450-Day RangeC$13.35MA: C$15.60▼C$18.6552-Week RangeC$7.50Now: C$13.05▼C$106.92Volume1.43 million shsAverage Volume1.41 million shsMarket CapitalizationC$1.47 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.Read More Beat the Market (BTM) Rank™ 1.1 Analyst's Opinion Consensus RatingAurora Cannabis has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of C$13.42, Aurora Cannabis has a potential upside of 2.9% from its current price of C$13.05.Amount of Analyst CoverageAurora Cannabis has only been the subject of 2 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesAurora Cannabis has received 525 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAurora Cannabis has received 471 “underperform” votes. (Add your “underperform” vote.)Community SentimentAurora Cannabis has received 52.71% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote “Outperform” if you believe ACB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -0.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.87 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:ACB Previous Symbol CUSIPN/A CIKN/A Webauroramj.com Phone+1-604-3625207Debt Debt-to-Equity Ratio15.20 Current Ratio3.17 Quick Ratio1.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$305.73 million Price / Sales4.80 Cash FlowC$2.10 per share Price / Cash Flow6.21 Book ValueC$35.80 per share Price / Book0.36Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees967 Outstanding Shares112,570,000Market CapC$1.47 billion Next Earnings Date9/9/2020 (Estimated) OptionableNot Optionable C$13.05 -0.30 (-2.25 %) (As of 08/13/2020 09:30 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ACB News and Ratings via Email Sign-up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Aurora Cannabis (TSE:ACB) Frequently Asked Questions How has Aurora Cannabis' stock been impacted by COVID-19? Aurora Cannabis' stock was trading at C$1.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACB shares have increased by 1,015.4% and is now trading at C$13.05. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Aurora Cannabis? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis. When is Aurora Cannabis' next earnings date? Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc (TSE:ACB) issued its quarterly earnings data on Monday, May, 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.01). The company had revenue of $5.18 million for the quarter, compared to analyst estimates of $7.44 million. View Aurora Cannabis' earnings history. What price target have analysts set for ACB? 10 Wall Street analysts have issued 1-year target prices for Aurora Cannabis' stock. Their forecasts range from C$2.00 to C$24.00. On average, they expect Aurora Cannabis' share price to reach C$13.42 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price. View analysts' price targets for Aurora Cannabis. Has Aurora Cannabis been receiving favorable news coverage? Press coverage about ACB stock has been trending extremely negative this week, InfoTrie reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aurora Cannabis earned a media sentiment score of -4.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news about Aurora Cannabis. Who are some of Aurora Cannabis' key competitors? Some companies that are related to Aurora Cannabis include Hikma Pharmaceuticals (HIK), Evotec (EVT), Aphria (APHA), Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), Hexo (HEXO), OrganiGram (OGI), HEXO (HEXO), Next Science (NXS), Amryt Pharma (AMYT), Benchmark (BMK), ICC Labs (ICC), cbdMD (YCBD) and Green Organic Dutchman (TGOD). View all competitors. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACBFF), Cronos Group (CRON), Green Organic Dutchman (TGOD), Micron Technology (MU), Alibaba Group (BABA) and Advanced Micro Devices (AMD). Who are Aurora Cannabis' key executives? Aurora Cannabis' management team includes the following people: Mr. Michael Singer, Exec. Chairman (Age 54)Mr. Terry Booth, Founder, CEO & Director (Age 54)Mr. Stephen Dobler, Founder, Pres & Director (Age 54)Mr. Glen Ibbott, Chief Financial OfficerMr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer What is Aurora Cannabis' stock symbol? Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB." How do I buy shares of Aurora Cannabis? Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Aurora Cannabis' stock price today? One share of ACB stock can currently be purchased for approximately C$13.05. How big of a company is Aurora Cannabis? Aurora Cannabis has a market capitalization of C$1.47 billion and generates C$305.73 million in revenue each year. Aurora Cannabis employs 967 workers across the globe. What is Aurora Cannabis' official website? The official website for Aurora Cannabis is auroramj.com. How can I contact Aurora Cannabis? Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207. This page was last updated on 8/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
